Insulin Lispro-Aabc
4 NDCs across 1 manufacturer|0 Generic,4 Brand
Insulin Lispro-Aabc is used to treat type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $90 million on Insulin Lispro-Aabc across 100,000 claims for 31,000 beneficiaries.
Insulin Lispro-Aabc is available as 4 NDCs from 1 manufacturer (0 generic, 4 brand), with NADAC prices from $7.88 to $20.29 per ML — the most expensive product costs about 2.6× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
0G / 4B
Manufacturers
1
competing in market
Price Spread
$7.88 – $20.29
per ML
7d Activity
avg -0.0% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing INSULIN LISPRO-AABC
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
LYUMJEV 200 UNIT/ML KWIKPEN | $20.2874 per ML | -0.05% |
LYUMJEV 100 UNIT/ML KWIKPEN | $10.1573 per ML | -0.05% |
LYUMJEV TEMPO PEN 100 UNIT/ML | $10.1381 per ML | — |
LYUMJEV 100 UNIT/ML VIAL | $7.8764 per ML | -0.02% |
Frequently Asked Questions
What is Insulin Lispro-Aabc used to treat?
Insulin Lispro-Aabc is used to treat type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Insulin Lispro-Aabc?
In 2024, Medicare Part D spent $90 million on Insulin Lispro-Aabc across 100,000 claims for 31,000 beneficiaries.
How many Insulin Lispro-Aabc products are on the market?
The Insulin Lispro-Aabc drug market contains 4 NDCs from 1 manufacturer — 0 generic and 4 brand products.
What is the price range for Insulin Lispro-Aabc?
NADAC reference prices for Insulin Lispro-Aabc range from $7.8764 to $20.2874 per ML — the most expensive product costs about 2.6× the cheapest.
Which manufacturers make Insulin Lispro-Aabc?
1 manufacturer lists Insulin Lispro-Aabc in NADAC. Ranked by number of NDCs, the largest are Eli Lilly and Company (4).
How has the price of Insulin Lispro-Aabc changed recently?
Over the past 7 days, 0 Insulin Lispro-Aabc NDCs rose and 3 fell, with a market-wide average change of -0.0%.